Man Group PLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.23 $91,494 - $107,991	-11,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $447,522 - $671,283	-53,024 Reduced 81.92%	11,700 $104,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $87,381 - $134,575	-10,950 Reduced 14.47%	64,724 $795,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $505,651 - $788,968	63,524 Added 522.83%	75,674 $616,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $65,610 - $162,445	12,150 New	12,150 $117,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.